Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma

Cancer Science

Volumn 104, Issue 12, 2013, Pages 1586-1592

  Tan, Fei ^a,b   Wahdan Alaswad, Reema ^b,c   Yan, Shuang ^b   Thiele, Carol J ^b   Li, Zhijie ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; DIHYDROPYRIMIDINASE LIKE PROTEIN 1; DIHYDROPYRIMIDINASE LIKE PROTEIN 3; MESSENGER RNA; RETINOIC ACID; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; UPREGULATION;

CELL DIFFERENTIATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE PROTEINS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROGNOSIS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SYMPATHETIC NERVOUS SYSTEM; TRETINOIN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84889583036     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12278     Document Type: Article

References (42)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 203-16.
2. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007; 369: 2106-20.
3. Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 2003; 4: 472-80.
4. Thiele CJ, Reynolds CP, Israel MA. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 1985; 313: 404-6.
5. Lotan R. Retinoids in cancer chemoprevention. FASEB J 1996; 10: 1031-9.
6. Matthay KK, Villablanca JG, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341: 1165-73.
7. Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 1995; 376: 509-14.
8. Byk T, Dobransky T, Cifuentes-Diaz C, Sobel A. Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product. J Neurosci 1996; 16: 688-701.
9. Cameron HA, McKay RD. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol 2001; 435: 406-17.
10. Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki M, Nonaka M. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 1996; 180: 157-63.
11. Minturn JE, Geschwind DH, Fryer HJ, Hockfield S. Early postmitotic neurons transiently express TOAD-64, a neural specific protein. J Comp Neurol 1995; 355: 369-79.
12. Minturn JE, Fryer HJ, Geschwind DH, Hockfield S. TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. J Neurosci 1995; 15: 6757-66.
13. Byk T, Ozon S, Sobel A. The Ulip family phosphoproteins-common and specific properties. Eur J Biochem 1998; 254: 14-24.
14. Horiuchi M, El Far O, Betz H. Ulip6, a novel unc-33 and dihydropyrimidinase related protein highly expressed in developing rat brain. FEBS Lett 2000; 480: 283-6.
15. Fukada M, Watakabe I, Yuasa-Kawada J et al. Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family. J Biol Chem 2000; 275: 37.
16. Inatome R, Tsujimura T, Hitomi T et al. Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. J Biol Chem 2000; 275: 27291-302.
17. Shih JY, Yang SC, Hong TM et al. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer Inst 2001; 93: 1392-400.
18. Pan SH, Chao YC, Chen HY et al. Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients. Lung Cancer 2010; 67: 93-100.
19. Chang CC, Shih JY, Jeng YM et al. Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst 2004; 96: 364-75.
20. Wu CC, Chen HC, Chen SJ et al. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008; 8: 316-32.
21. Gao X, Pang J, Li LY et al. Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer. Oncogene 2010; 29: 4555-66.
22. Gaetano C, Matsuo T, Thiele CJ. Identification and characterization of a retinoic acid-regulated human homologue of the unc-33-like phosphoprotein gene (hUlip) from neuroblastoma cells. J Biol Chem 1997; 272: 12.
23. Woo CW, Tan F, Cassano H, Lee J, Lee KC, Thiele CJ. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma. Pediatr Blood Cancer 2008; 50: 208-12.
24. Jaboin J, Kim CJ, Kaplan DR, Thiele CJ. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway. Cancer Res 2002; 62: 6756-63.
25. Rogemond V, Auger C, Giraudon P et al. Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition. J Biol Chem 2008; 283: 14.
26. Thiele CJ, Israel MA. Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate. Exp Cell Biol 1988; 56: 321-33.
27. Thiele CJ. Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells. Prog Clin Biol Res 1991; 366: 151-6.
28. Nakamura M, Matsuo T, Stauffer J, Neckers L, Thiele CJ. Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and an N-myc-independent decrease in Skp2. Cell Death Differ 2003; 10: 230-9.
29. Souopgui J, Klisch TJ, Pieler T, Henningfeld KA. Expression and regulation of Xenopus CRMP-4 in the developing nervous system. Int J Dev Biol 2007; 51: 339-43.
30. Charrier E, Reibel S, Rogemond V, Aguera M, Thomasset N, Honnorat J. Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Mol Neurobiol 2003; 28: 51-64.
31. Tanaka H, Morimura R, Ohshima T. Dpysl2 (CRMP2) and Dpysl3(CRMP4) phosphorylation by Cdk5 and DYRK2 is required for proper positioning of Rohon-Beard neurons and neural crest cells during neurulation in zebrafish. Dev Biol 2012; 370: 223-36.
32. Fontan-Gabas L, Oliemuller E, Martinez-Irujo JJ, de Miguel C, Rouzaut A. All-trans-retinoic acid inhibits collapsin response mediator protein-2 transcriptional activity during SH-SY5Y neuroblastoma cell differentiation. FEBS J 2007; 274: 498-511.
33. Ong Tone S, Dayanandan B, Fournier AE, Mandato CA. GSK3 regulates mitotic chromosomal alignment through CRMP4. PLoS ONE 2010; 5: e14345.
34. Alabed YZ, Pool M, Ong Tone S, Sutherland C, Fournier AE. GSK3 beta regulates myelin-dependent axon outgrowth inhibition through CRMP4. J Neurosci 2010; 30: 5635-43.
35. Li Z, Tan F, Thiele CJ. Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells. Mol Cancer Ther 2007; 6: 3113-21.
36. Oliemuller E, Peláez R, Garasa S. Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC. Int J Cancer 2013; 132: 1986-95.
37. Kohl NE, Gee CE, Alt FW. Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science 1984; 226: 1335-7.
38. Nie Z, Hu G, Wei G et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012; 151: 68-79.
39. Wang C, Liu Z, Woo CW et al. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res 2012; 72: 315-24.
40. Molenaar JJ, Koster J, Zwijnenburg DA et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 2012; 483: 589-93.
41. Alabed YZ, Pool M, Ong Tone S, Fournier AE. Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition. J Neurosci 2007; 27: 1702-11.
42. Hiroshima Y, Nakamura F, Miyamoto H et al. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer. Ann Surg Oncol 2012; doi: 10.1245/s10434-012-2491-3 [Epub ahead of print].